Paradigm shift in neuroprotection by NMDA receptor blockade: Memantine and beyond
The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Abstract
Neuroprotective drugs tested in clinical trials, particularly those that block N-methyl-D-aspartate-sensitive glutamate receptors (NMDARs), have failed miserably in large part because of intolerable side effects. However, one such drug, memantine, was recently approved by the European Union and the US FDA for the treatment of dementia following our group's discovery of its clinically tolerated mechanism of action. Here, we review the molecular basis for memantine efficacy in neurological diseases that are mediated, at least in part, by overactivation of NMDARs, producing excessive Ca(2+) influx through the receptor's associated ion channel and consequent free-radical formation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The discrepancy in ketamine IC50 values between these two studies might be explained by the concentration of agonist used (50 μM versus 1 mM glutamate), as higher agonist concentrations allow non-competitive antagonists, e.g. ketamine, to block more effectively due to a greater number of open channels”
From Mechanisms of ketamine and its metabolites as antidepressants (2022) · cites this paper as Lipton, 2006
Citations
Cites
Glutamate neurotoxicity and diseases of the nervous system
CHOI, D. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 7,972 · cited 1×
“D-aspartate receptor channel blockers memantine, MRZ 2/579 and other amino-alkyl-cyclohexanes antagonise 5-HT(3) receptor currents in cultured HEK293 and N1E-115 cell systems in a non-competitive manner.”
BackgroundAlzheimer's Disease: Genes, Proteins, and Therapy
Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063
Magnesium gates glutamate-activated channels in mouse central neurones
Nowak, L., Bregestovski, P., Ascher, P., Herbet, A., & Prochiantz, A. (1984) · Nature · doi:10.1038/307462a0 · Cited by 4,043
Glycine potentiates the NMDA response in cultured mouse brain neurons
Johnson, J. W., & Ascher, P. (1987) · Nature · doi:10.1038/325529a0 · Cited by 3,139 · cited 1×
“The NR2 family of NMDAR subunits contains a binding site for glutamate, the endogenous agonist, whereas the NR1 subunit binds glycin”
BackgroundVoltage-dependent block by Mg2+ of NMDA responses in spinal cord neurones
Mayer, M. L., Westbrook, G. L., & Guthrie, P. B. (1984) · Nature · doi:10.1038/309261a0 · Cited by 2,893
Excitatory Amino Acids as a Final Common Pathway for Neurologic Disorders
Epstein, F. H., Lipton, S. A., & Rosenberg, P. A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403033300907 · Cited by 2,658 · cited 1×
“kon Channel + MEM ↔ Channel–MEM (Blocked channel) (1)”
Self-citationMolecular diversity of glutamate receptors and implications for brain function
Nakanishi, S. (1992) · Science · doi:10.1126/science.1329206 · Cited by 2,543
Heteromeric NMDA receptors: molecular and functional distinction of subtypes
Monyer, H., Sprengel, R., Schoepfer, R., Herb, A., Higuchi, M., Lomeli, H., Burnashev, N., Sakmann, B., & Seeburg, P. H. (1992) · Science · doi:10.1126/science.256.5060.1217 · Cited by 2,541
Lipton, S. A., Choi, Y.-B., Pan, Z.-H., Lei, S. Z., Chen, H.-S. V., Sucher, N. J., Loscalzo, J., Singel, D. J., & Stamler, J. S. (1993) · Nature · doi:10.1038/364626a0 · Cited by 2,433
Self-citationNitric oxide mediates glutamate neurotoxicity in primary cortical cultures.
Dawson, V. L., Dawson, T. M., London, E. D., Bredt, D. S., & Snyder, S. H. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.14.6368 · Cited by 2,174
Memantine in Moderate-to-Severe Alzheimer's Disease
Reisberg, B., Doody, R., Stöffler, A., Schmitt, F., Ferris, S., & Möbius, H. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa013128 · Cited by 2,043
Handbook of Experimental Pharmacology.
Meakin, J. W. (1971) · Archives of Internal Medicine · doi:10.1001/archinte.1971.00310230151026 · Cited by 1,959
Bonfoco, E., Krainc, D., Ankarcrona, M., Nicotera, P., & Lipton, S. A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7162 · Cited by 1,958
Self-citationAnkarcrona, M., Dypbukt, J. M., Bonfoco, E., Zhivotovsky, B., Orrenius, S., Lipton, S. A., & Nicotera, P. (1995) · Neuron · doi:10.1016/0896-6273(95)90186-8 · Cited by 1,884
Self-citationExcitatory amino acid neurotoxicity and neurodegenerative disease
Meldrum, B., & Garthwaite, J. (1990) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(90)90184-a · Cited by 1,771 · cited 2×
“These transformations lead to Equations (4) and (5):”
BackgroundExtrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways
Hardingham, G. E., Fukunaga, Y., & Bading, H. (2002) · Nature Neuroscience · doi:10.1038/nn835 · Cited by 1,686 · cited 1×
“Additionally, the NR2B subunit predominates in extrasynaptic rather than synaptic NMDARs, and it is thought that excessive stimulation of extrasynaptic (NR2B predominant) receptors might contribute to neurotoxicity, whereas physiological synaptic activity (predominantly containing NR2A>NR2B subunits) might be neuropro…”
BackgroundMattson, M., Cheng, B., Davis, D., Bryant, K., Lieberburg, I., & Rydel, R. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-02-00376.1992 · Cited by 1,627
Requirement for Glycine in Activation of NMDA-Receptors Expressed in Xenopus Oocytes
Kleckner, N. W., & Dingledine, R. (1988) · Science · doi:10.1126/science.2841759 · Cited by 1,422
Tariot, P. N., Farlow, M. R., Grossberg, G. T., Graham, S. M., McDonald, S., Gergel, I., & for the Memantine Study Group (2004) · JAMA · doi:10.1001/jama.291.3.317 · Cited by 1,403 · cited 1×
“Another study reported that, in combination with donepezil (Aricept; Eisai/Pfizer), memantine treatment improved cognitive function to some degree in moderate-to-severe Alzheimer's patient”
d -Serine is an endogenous ligand for the glycine site of the N -methyl- d -aspartate receptor
Mothet, J.-P., Parent, A. T., Wolosker, H., Brady, R. O., Linden, D. J., Ferris, C. D., Rogawski, M. A., & Snyder, S. H. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.9.4926 · Cited by 1,137 · cited 1×
“Although levels of glycine are tenfold higher than D -serine, recent reports indicate that endogenous D -serine and not glycine is the dominant endogenous co-agonist for NMDAR-mediated neurotoxicit”
BackgroundS-nitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siah1 binding
Hara, M. R., Agrawal, N., Kim, S. F., Cascio, M. B., Fujimuro, M., Ozeki, Y., Takahashi, M., Cheah, J. H., Tankou, S. K., Hester, L. D., et al. (2005) · Nature Cell Biology · doi:10.1038/ncb1268 · Cited by 1,070
The Toxic Effect of Sodium L-Glutamate on the Inner Layers of the Retina
LUCAS, D. R., & NEWHOUSE, J. P. (1957) · Archives of Ophthalmology · doi:10.1001/archopht.1957.00940010205006 · Cited by 1,063
Excitotoxity and the NMDA receptor
Rothman, S. M., & Olney, J. W. (1987) · Trends in Neurosciences · doi:10.1016/0166-2236(87)90177-9 · Cited by 1,058 · cited 1×
“These transformations lead to Equations (4) and (5):”
BackgroundMechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures
Dawson, V., Dawson, T., Bartley, D., Uhl, G., & Snyder, S. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-06-02651.1993 · Cited by 1,014
N-methyl-D-aspartic acid receptor structure and function
McBain, C. J., & Mayer, M. L. (1994) · Physiological Reviews · doi:10.1152/physrev.1994.74.3.723 · Cited by 976
Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis.
Quigley, H. A., Nickells, R. W., Kerrigan, L. A., Pease, M. E., Thibault, D., & Zack, D. J. (1995) · PubMed · Cited by 935
Parsons, C. G., Danysz, W., & Quack, G. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00019-2 · Cited by 878 · cited 1×
“The neuroprotective properties of memantine have been studied in a large number of in vitro and in vivo animal models by several laboratorie”
BackgroundWolosker, H., Blackshaw, S., & Snyder, S. H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13409 · Cited by 811
Functional characterization of a heteromeric NMDA receptor channel expressed from cloned cDNAs
Meguro, H., Mori, H., Araki, K., Kushiya, E., Kutsuwada, T., Yamazaki, M., Kumanishi, T., Arakawa, M., Sakimura, K., & Mishina, M. (1992) · Nature · doi:10.1038/357070a0 · Cited by 798
Huettner, J. E., & Bean, B. P. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.4.1307 · Cited by 751
Pharmacology of Cerebral Ischemia
Krieglstein, J. (1989) · International Clinical Psychopharmacology · doi:10.1097/00004850-198901000-00011 · Cited by 677
Chen, H., Pellegrini, J., Aggarwal, S., Lei, S., Warach, S., Jensen, F., & Lipton, S. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-11-04427.1992 · Cited by 629
Self-citationβ-Amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage
Koh, J.-Y., Yang, L. L., & Cotman, C. W. (1990) · Brain Research · doi:10.1016/0006-8993(90)91355-k · Cited by 617
NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury
Salter, M. G., & Fern, R. (2005) · Nature · doi:10.1038/nature04301 · Cited by 553 · cited 1×
“Additionally, very recent evidence demonstrates that NMDARs are also present on the processes of oligodendrocytes, constituting the myelin sheath of CNS axons, and contribute to injury, cell death and demyelination from exposure to glutamat”
BackgroundOrgogozo, J.-M., Rigaud, A.-S., Stöffler, A., Möbius, H.-J., & Forette, F. (2002) · Stroke · doi:10.1161/01.str.0000020094.08790.49 · Cited by 539
Excitotoxicity and the NMDA receptor -- still lethal after eight years
Rothman, S. (1995) · Trends in Neurosciences · doi:10.1016/0166-2236(95)93869-y · Cited by 508
NMDA receptor pathways as drug targets
Kemp, J. A., & McKernan, R. M. (2002) · Nature Neuroscience · doi:10.1038/nn936 · Cited by 476 · cited 1×
“For this reason some authorities have suggested developing antagonists that are selective for particular subunits, such as NR2B, which is predominantly present in the forebrai”
BackgroundThe Neuropharmacological Basis for the Use of Memantine in the Treatment of Alzheimer's Disease
Rogawski, M. A., & Wenk, G. L. (2003) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2003.tb00254.x · Cited by 436
Stern-Bach, Y., Bettler, B., Hartley, M., Sheppard, P. O., O'Hara, P. J., & Heinemann, S. F. (1994) · Neuron · doi:10.1016/0896-6273(94)90420-0 · Cited by 429
Molecular basis of NMDA receptor-coupled ion channel modulation by S-nitrosylation
Choi, Y.-B., Tenneti, L., Le, D. A., Ortiz, J., Bai, G., Chen, H.-S. V., & Lipton, S. A. (2000) · Nature Neuroscience · doi:10.1038/71090 · Cited by 425
Self-citationBrain Damage in Infant Mice following Oral Intake of Glutamate, Aspartate or Cysteine
OLNEY, J. W., & HO, O.-L. (1970) · Nature · doi:10.1038/227609b0 · Cited by 384 · cited 1×
“; Olney later coined the term 'excitotoxicity' to describe the even”
BackgroundMolecular basis of glutamate toxicity in retinal ganglion cells
Sucher, N. J., Lipton, S. A., & Dreyer, E. B. (1997) · Vision Research · doi:10.1016/s0042-6989(97)00047-3 · Cited by 377 · cited 1×
“Neurons protected in this manner both in culture and in vivo include cerebrocortical neurons, cerebellar neurons and retinal neuron”
BackgroundSelf-citationCysteine regulation of protein function – as exemplified by NMDA-receptor modulation
Lipton, S. A., Choi, Y.-B., Takahashi, H., Zhang, D., Li, W., Godzik, A., & Bankston, L. A. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(02)02245-2 · Cited by 375 · cited 1×
“Additionally, other redox-sensitive cysteine residues that are not susceptible to S -nitrosylation can nonetheless inhibit channel activity by virtue of their redox-sensitive capacity to form disulphide bond”
BackgroundSelf-citationOLNEY, J. W. (1969) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-196907000-00007 · Cited by 352 · cited 1×
“; Olney later coined the term 'excitotoxicity' to describe the even”
BackgroundMemantine is a potent blocker of N-methyl-D-aspartate (NMDA) receptor channels
Bormann, J. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90385-3 · Cited by 351 · cited 1×
“Work at the small German pharmaceutical company Merz first suggested that the drug was a quite 'potent' NMDAR inhibito”
BackgroundLees, K. R., Asplund, K., Carolei, A., Davis, S. M., Diener, H.-C., Kaste, M., Orgogozo, J.-M., & Whitehead, J. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02326-6 · Cited by 309
Mitochondrial and extramitochondrial apoptotic signaling pathways in cerebrocortical neurons
Budd, S. L., Tenneti, L., Lishnak, T., & Lipton, S. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.100121097 · Cited by 284
Self-citationSacco, R. L., DeRosa, J. T., Haley, Jr., Levin, B., Ordronneau, P., Phillips, S. J., Rundek, T., Snipes, R. G., Thompson, J. L. P., & for the GAIN Americas Investigators (2001) · JAMA · doi:10.1001/jama.285.13.1719 · Cited by 283 · cited 1×
“As a result, prior drugs lacked clinical tolerability, representing the major (but not the only) factor involved in the failure of these drugs in clinical trials for stroke, traumatic brain injury and Huntington's diseas”
BackgroundChen, H. S., & Lipton, S. A. (1997) · The Journal of Physiology · doi:10.1113/jphysiol.1997.sp021909 · Cited by 282
Self-citationWang, H., Yu, S.-W., Koh, D. W., Lew, J., Coombs, C., Bowers, W., Federoff, H. J., Poirier, G. G., Dawson, T. M., & Dawson, V. L. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3461-04.2004 · Cited by 282
Chronic low-dose glutamate is toxic to retinal ganglion cells. Toxicity blocked by memantine.
Vorwerk, C. K., Lipton, S. A., Zurakowski, D., Hyman, B. T., Sabel, B. A., & Dreyer, E. B. (1996) · PubMed · Cited by 281
Self-citationHarkany, T., Ábrahám, I., Timmerman, W., Laskay, G., Tóth, B., Sasvári, M., Kónya, C., Sebens, J. B., Korf, J., Nyakas, C., et al. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00164.x · Cited by 273
Neuroprotection by memantine against neurodegeneration induced by β-amyloid(1–40)
Miguel-Hidalgo, J. J., Alvarez, X. A., Cacabelos, R., & Quack, G. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03731-9 · Cited by 265
Identification by mutagenesis of a Mg2+ -block site of the NMDA receptor channel
Mori, H., Masaki, H., Yamakura, T., & Mishina, M. (1992) · Nature · doi:10.1038/358673a0 · Cited by 262
Lipton, S. A. (1993) · Trends in Neurosciences · doi:10.1016/0166-2236(93)90198-u · Cited by 256
Self-citationAmantadine Inhibits NMDA Receptors by Accelerating Channel Closure during Channel Block
Blanpied, T. A., Clarke, R. J., & Johnson, J. W. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4262-04.2005 · Cited by 251 · cited 1×
“Trapping of a related but less potent NMDAR antagonist, amantadine, has recently been reported to account, at least in part, for the drug's actio”
BackgroundTrapping Channel Block of NMDA-Activated Responses By Amantadine and Memantine
Blanpied, T. A., Boeckman, F. A., Aizenman, E., & Johnson, J. W. (1997) · Journal of Neurophysiology · doi:10.1152/jn.1997.77.1.309 · Cited by 249
Caspase Cascades in Human Immunodeficiency Virus-Associated Neurodegeneration
Garden, G. A., Budd, S. L., Tsai, E., Hanson, L., Kaul, M., D'Emilia, D. M., Friedlander, R. M., Yuan, J., Masliah, E., & Lipton, S. A. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-10-04015.2002 · Cited by 219 · cited 1×
“Importantly, the initial manifestation of these more subtle insults produces synaptic, dendritic and possibly axonal damage in the early stages of diseas”
BackgroundSelf-citationShleper, M., Kartvelishvily, E., & Wolosker, H. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3190-05.2005 · Cited by 216 · cited 1×
“Although levels of glycine are tenfold higher than D -serine, recent reports indicate that endogenous D -serine and not glycine is the dominant endogenous co-agonist for NMDAR-mediated neurotoxicit”
BackgroundChen, H.-S. V., Wang, Y. F., Rayudu, P. V., Edgecomb, P., Neill, J. C., Segal, M. M., Lipton, S. A., & Jensen, F. E. (1998) · Neuroscience · doi:10.1016/s0306-4522(98)00163-8 · Cited by 202
Self-citationRammes, G., Rupprecht, R., Ferrari, U., Zieglgänsberger, W., & Parsons, C. G. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01872-9 · Cited by 200
Nitric oxide mediates N-methyl-d-aspartate receptor-induced activation of p21ras
Yun, H.-Y., Gonzalez-Zulueta, M., Dawson, V. L., & Dawson, T. M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.10.5773 · Cited by 190
Emerging treatments for stroke in humans
Koroshetz, W. J., & Moskowitz, M. A. (1996) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(96)10020-1 · Cited by 189
Calcium, free radicals and excitotoxins in neuronal apoptosis
Lipton, S. A., & Nicotera, P. (1998) · Cell Calcium · doi:10.1016/s0143-4160(98)90115-4 · Cited by 188
Self-citationMemantine Improves Spatial Learning in a Transgenic Mouse Model of Alzheimer’s Disease
Minkeviciene, R., Banerjee, P., & Tanila, H. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.071027 · Cited by 184
Role of Caspases in N‐Methyl‐d‐Aspartate‐Induced Apoptosis in Cerebrocortical Neurons
Tenneti, L., D'Emilia, D. M., Troy, C. M., & Lipton, S. A. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71030946.x · Cited by 169
Self-citationPharmacology of cerebral ischemia
Polinsky, R. J. (1995) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(95)90034-9 · Cited by 164
Neuroprotective effect of memantine demonstrated in vivo and in vitro
el Nasr, M. S., Peruche, B., Roβberg, C., Mennel, H.-D., & Krieglstein, J. (1990) · European Journal of Pharmacology · doi:10.1016/0014-2999(90)90206-l · Cited by 159 · cited 1×
“However, our group discovered a mechanism through which an old drug, memantine, was not only capable of blocking excitotoxic cell deat”
BackgroundMemantine prevents HIV coat protein‐induced neuronal injury in vitro
Lipton, S. A. (1992) · Neurology · doi:10.1212/wnl.42.7.1403 · Cited by 156
Self-citationLi, L., Sengupta, A., Haque, N., Grundke-Iqbal, I., & Iqbal, K. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.04.047 · Cited by 151
Neuroprotection by NMDA Receptor Antagonists in a Variety of Neuropathologies
Palmer, G. (2001) · Current Drug Targets · doi:10.2174/1389450013348335 · Cited by 146
Okamoto, S.-I., Li, Z., Ju, C., Schölzke, M. N., Mathews, E., Cui, J., Salvesen, G. S., Bossy-Wetzel, E., & Lipton, S. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.022036399 · Cited by 139
Self-citationZeevalk, G. D., & Nicklas, W. J. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb08430.x · Cited by 138
Chen, H.-S. V., & Lipton, S. A. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.085142 · Cited by 112
Self-citationRogawski, M. A. (2000) · Amino Acids · doi:10.1007/s007260070042 · Cited by 105
Effects of memantine on recombinant rat NMDA receptors expressed in HEK 293 cells
Bresink, I., Benke, T. A., Collett, V. J., Seal, A. J., Parsons, C. G., Henley, J. M., & Collingridge, G. L. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15971.x · Cited by 102
Hickenbottom, S., & Grotta, J. (1998) · Seminars in Neurology · doi:10.1055/s-2008-1040901 · Cited by 95
Sobolevsky, A. I., Koshelev, S. G., & Khodorov, B. I. (1998) · The Journal of Physiology · doi:10.1111/j.1469-7793.1998.047bf.x · Cited by 89
Delayed administration of memantine prevents N‐methyl‐ D ‐aspartate receptor‐mediated neurotoxicity
Pellegrini, J. W., & Lipton, S. A. (1993) · Annals of Neurology · doi:10.1002/ana.410330414 · Cited by 89
Self-citationBerliocchi, L., Fava, E., Leist, M., Horvat, V., Dinsdale, D., Read, D. J., & Nicotera, P. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200406126 · Cited by 87 · cited 1×
“Importantly, the initial manifestation of these more subtle insults produces synaptic, dendritic and possibly axonal damage in the early stages of diseas”
BackgroundLipton, S. A., & Chen, H.-S. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401344 · Cited by 77
Self-citationPotential and Current Use of N-Methyl-D-Aspartate (NMDA) Receptor Antagonists in Diseases of Aging
Le, D. A., & Lipton, S. A. (2001) · Drugs & Aging · doi:10.2165/00002512-200118100-00001 · Cited by 72 · cited 1×
“The surprisingly yet clinically tolerated action of uncompetitive, low-affinity/fast off-rate drugs in animal models and clinical studies of both acute and chronic neurological disorders suggests that memantine and newer derivatives could become very important weapons in the fight against neuronal damag”
BackgroundSelf-citationChapter 6 Redox modulation of the NMDA receptor by NO-related species
Lipton, S. A., Rayudu, P. V., Choi, Y., Sucher, N. J., & Chen, H.-S. V. (1998) · Progress in brain research · doi:10.1016/s0079-6123(08)63201-x · Cited by 70
Self-citationKarschin, A., Aizenman, E., & Lipton, S. A. (1988) · Journal of Neuroscience · doi:10.1523/jneurosci.08-08-02895.1988 · Cited by 68
Self-citationMemantine reduces alterations to the mammalian retina, in situ, induced by ischemia
Osborne, N. N. (1999) · Visual Neuroscience · doi:10.1017/s0952523899161017 · Cited by 66 · cited 1×
“Neurons protected in this manner both in culture and in vivo include cerebrocortical neurons, cerebellar neurons and retinal neuron”
BackgroundLipton, S. A. (2004) · Nature · doi:10.1038/428473a · Cited by 64
Self-citationMolecular mechanisms of trauma-induced neuronal degeneration.
Lipton, S. A. (1993) · PubMed · Cited by 61
Self-citationTranscriptional or translational inhibition blocks low dose NMDA-mediated cell death
Dreyer, E. B., Zhang, D., & Lipton, S. A. (1995) · NeuroReport · doi:10.1097/00001756-199504190-00029 · Cited by 57
Self-citationModifications of neuronal phosphorylated τ immunoreactivity induced by NMDA toxicity
Couratier, P., Lesort, M. J., Sindou, P., Esclaire, F., Yardin, C., & Hugon, J. (1996) · Molecular and Chemical Neuropathology · doi:10.1007/bf02815108 · Cited by 55
Dreyer, E. B., & Lipton, S. A. (1999) · JAMA · doi:10.1001/jama.281.4.306 · Cited by 52
Self-citationT�pper, R., Gehrmann, J., Banati, R. B., Schwarz, M., Block, F., Noth, J., & Kreutzberg, G. W. (1994) · Acta Neuropathologica · doi:10.1007/bf00294255 · Cited by 50
Zurakowski, D., Vorwerk, C. K., Gorla, M., Kanellopoulos, A. J., Chaturvedi, N., Grosskreutz, C. L., Lipton, S. A., & Dreyer, E. B. (1998) · Vision Research · doi:10.1016/s0042-6989(98)00003-0 · Cited by 49
Self-citationExcitatory mechanisms in retinal ganglion cell death in primary open angle glaucoma (POAG).
Dreyer, E. B., & Grosskreutz, C. (1997) · PubMed · Cited by 49
Reiser, G., Binmöller, F.-J., & Koch, R. (1988) · Brain Research · doi:10.1016/0006-8993(88)91630-7 · Cited by 47 · cited 1×
“Finally, memantine can also block 5-hydroxytryptamine (5-HT) 3 receptor-channels and α 7 nicotinic receptor channels but, when measured at equilibrium, at apparently higher concentrations than those that block NMDAR-channel”
BackgroundNeuroprotection in Acute Ischaemic Stroke
Lutsep, H. L., & Clark, W. M. (1999) · Drugs in R&D · doi:10.2165/00126839-199901010-00001 · Cited by 44
Saving the Nerve from Glaucoma: Memantine to Caspaces
Naskar, R., Vorwerk, C. K., & Dreyer, E. B. (1999) · Seminars in Ophthalmology · doi:10.3109/08820539909061468 · Cited by 19
Organic calcium channel blockers enhance [3H]purine release from rat brain cortical synaptosomes
Wu, P. H., Moron, M. A., & Barraco, R. A. (1984) · Neurochemical Research · doi:10.1007/bf00964798 · Cited by 9
Winblad (1999) · doi:10.1002/(sici)1099-1166(199902)14:2
Research works printed but not linked: 5
- Chen, H. -S. V. & Lipton, S. A. in Post Genomic Drug Discovery Research (ed. Huang, Z.) (John Wiley & Sons, Hoboken, NJ (in the press).
- Navia, B. A., Yiannoutsos, C., Ellis, R., Schifitto, G., Nath, A., Shriver, S., Millar, L. & Lipton, S. A. Memantine may prevent further cognitive decline in subjects with AIDS Dementia Complex with detectable CSF HIV RNA. Neurology 64 (Suppl. 1), A247–A238 (2005).
- Lipton, S. A., Rayudu, P. V., Choi, Y. -B., Sucher, N. J. & Chen, H. -S. V. in Prog Brain Res. (eds Mize, V., Dawson, T. M., Dawson, M. & Friedlander, M.) 73–82 (Elsevier, Amsterdam, 1998).
- Káradóttir, R., Cavelier, P., Bergersen, L. H. & Atwell, D. NMDA receptors in oligodendrocyte physiology and pathology. Nature (in the press).
- Micu, I. et al. NMDA receptors mediate Ca accumulation in central nervous system myelin during chemical ischemia. Nature (in the press).
Cited by
The Science of Stroke: Mechanisms in Search of Treatments
Moskowitz, M. A., Lo, E. H., & Iadecola, C. (2010) · Neuron · doi:10.1016/j.neuron.2010.07.002 · Cited by 1,930
How were new medicines discovered?
Swinney, D. C., & Anthony, J. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3480 · Cited by 1,812
Oxidative Stress, Synaptic Dysfunction, and Alzheimer’s Disease
Tönnies, E., & Trushina, E. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161088 · Cited by 1,750
“Importantly, memantine has greater affinity to non-synaptic NMDA receptors, which are implicated in excitotoxicity associated with the glutamate spillover and have distinctly different composition of receptor subunits [164, 165].”
BackgroundFunctional Repression of cAMP Response Element in 6-Hydroxydopamine-treated Neuronal Cells
Chalovich, E. M., Zhu, J.-H., Caltagarone, J., Bowser, R., & Chu, C. T. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602632200 · Cited by 1,371
Lacor, P. N., Buniel, M. C., Furlow, P. W., Sanz Clemente, A., Velasco, P. T., Wood, M., Viola, K. L., & Klein, W. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3501-06.2007 · Cited by 1,188
“Because the Alzheimer’s drug Namenda (memantine) is thought to function therapeutically as an openchannel blocker of NMDA receptors (Lipton, 2006) and NMDA receptors codistribute in hippocampal cultures with ADDLs, we tested whether memantine might exhibit efficacy in blocking ADDL-induced drebrin…”
Background
Metadata
- Authors
- Lipton, S. A.
- Affiliations
- Sanford Burnham Prebys Medical Discovery Institute (US)
- Corresponding author
- Lipton, Stuart A.
- ORCID
- Lipton, Stuart A.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2006-01-20
- Volume
- 5
- Issue
- 2
- Pages
- 160-170
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W1981238903
- Cited by
- 909
- References
- 98
- Citations by year
- 2026: 39 · 2025: 31 · 2024: 32 · 2023: 31 · 2022: 40 · 2021: 41 · 2020: 51 · 2019: 42 · 2018: 36 · 2017: 40 · 2016: 48 · 2015: 51 · 2014: 47 · 2013: 48 · 2012: 52
- FWCI
- 5.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- memantine, NMDA receptor antagonists, neuroprotection, Alzheimer's disease, dementia, glutamate excitotoxicity, calcium influx, free radicals, adverse drug reactions, clinical trial failure, NMDA receptor overactivation
- MeSH terms
- Animals, Humans, Memantine, Neurotoxins, Receptors, N-Methyl-D-Aspartate, Excitatory Amino Acid Antagonists, Neuroprotective Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.